Alternate Health Club vs Cost Plus Drugs
An in-depth comparison of two leading GLP-1 Providers
WeightLossRankings.org is reader-supported. When you buy through links on our site, we may earn an affiliate commission. Learn more
Alternate Health Club
Best for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platformStarting at $129/mo
Cost Plus Drugs
Best for the cheapest transparent-pricing brand-name Ozempic channelStarting at $279/mo
Side-by-Side Comparison
| Feature | Alternate Health Club | Cost Plus Drugs |
|---|---|---|
| Overall Score | 7.3/10 | ✓8.5/10 |
| Starting Price | ✓$129/mo | $279/mo |
| Editorial Rating | 3.7 ★ /5 | ✓4.3 ★ /5 |
| Features | ✓6 features | 5 features |
| States Available | 0 | ✓50 |
| Compounded | ✓ Yes | — |
| Brand Name | — | ✓ Yes |
| FSA/HSA Accepted | — | — |
| FDA Warnings | None | None |
Pros & Cons
Alternate Health Club
Pros
- ✓$129/month compounded semaglutide is in the cheapest decile of the US compounded telehealth market
- ✓$169/month compounded tirzepatide is competitive with established compounded-tirz platforms
- ✓Complimentary workout & dietary plans included alongside medication — most peer platforms don't bundle this
- ✓LegitScript Verified seal displayed in the footer
- ✓U.S.-licensed clinicians explicitly mentioned
Cons
- ✗Parent company / legal entity name NOT publicly disclosed — material YMYL transparency gap
- ✗State of incorporation NOT disclosed
- ✗Per-state availability NOT enumerated — verify your state ships before committing
- ✗Pharmacy partners NOT publicly named — material YMYL transparency gap
- ✗Lab work NOT clearly disclosed as included
- ✗Billing cadence (monthly vs quarterly vs annual) NOT clearly disclosed on home page
- ✗First-month discount or trial offer NOT disclosed
Cost Plus Drugs
Pros
- ✓Transparent pricing formula: wholesale acquisition cost + 15% markup + $5 pharmacy fee — publicly disclosed and the same for everyone (no insurance gatekeeping, no negotiated PBM rebate games)
- ✓~$279/month for branded Ozempic is meaningfully below retail pharmacy list prices for the same FDA-approved manufacturer product
- ✓Mark Cuban's PBM-disrupting platform has earned editorial credibility from Forbes Health, Wired, and KFF Health News for its pricing transparency
- ✓Ships to all 50 states; same FDA-approved Novo Nordisk Ozempic, no compounded reformulation
- ✓Partnered with 9amHealth for telehealth prescribing — you can get the prescription separately and pay Cost Plus pricing for fulfillment
Cons
- ✗Pharmacy fulfillment only — no telehealth intake, no prescribing clinicians on staff. You need a valid Ozempic prescription from an external clinician (PCP, endocrinologist, or telehealth provider) before Cost Plus can fill it
- ✗Ozempic is FDA-indicated for type 2 diabetes, not chronic weight management — your prescribing clinician's documentation matters for off-label weight-loss use
- ✗Wegovy availability through Cost Plus has historically been spotty — verify current Wegovy SKU status before assuming it ships
- ✗No compounded semaglutide or tirzepatide — brand-only model
- ✗No clinical follow-up included — fulfillment-only model means side-effect monitoring is on your prescribing clinician
Our Verdict
Cost Plus Drugs edges out Alternate Health Club with a higher overall score of 8.5/10 and is particularly strong for the cheapest transparent-pricing brand-name Ozempic channel. Alternate Health Club remains a solid alternative, especially if you're looking for patients who want compounded GLP-1 bundled with structured workout and dietary plans, at a competitive monthly price, and who are comfortable verifying state coverage + billing terms directly with the platform.
Glossary references
Key terms in this article, linked to their canonical definitions.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Wegovy®, Ozempic®, and Rybelsus® are trademarks of Novo Nordisk A/S. Mounjaro® and Zepbound® are trademarks of Eli Lilly and Company. All other product names and trademarks referenced on this page belong to their respective owners. WeightLossRankings.org is not affiliated with any pharmaceutical manufacturer. See trademark disclaimer.